Showing results (441-450 of 592) with videos related to

Sort By:
Pageof 60
Cancer Treatment Reviews|August 28, 2023
Tucatinib's journey from clinical development to clinical practice: New horizons for HER2-positive metastatic disease and promising prospects for brain metastatic spreadCarmen Criscitiello, Chiara Corti, Michelino De Laurentiis, et al.
Clinical Genitourinary Cancer|November 27, 2019
Survival Outcomes From a Cumulative Analysis of Worldwide Observational Studies on Sequential Use of New Agents in Metastatic Castration-Resistant Prostate CancerOrazio Caffo, Michel Wissing, Diletta Bianchini, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 28, 2018
Metformin Enhances Cisplatin-Induced Apoptosis and Prevents Resistance to Cisplatin in Co-mutated KRAS/LKB1 NSCLCMassimo Moro, Elisa Caiola, Monica Ganzinelli, et al.
Breast (Edinburgh, Scotland)|August 28, 2021
Evidence-based tailored nutrition educational intervention improves adherence to dietary guidelines, anthropometric measures and serum metabolic biomarkers in early-stage breast cancer patients: A prospective interventional studyIlaria Trestini, Isabella Sperduti, Alberto Caldart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2017
LKB1 Expression Correlates with Increased Survival in Patients with Advanced Non-Small Cell Lung Cancer Treated with Chemotherapy and BevacizumabLaura Bonanno, Angela De Paoli, Elisabetta Zulato, et al.
Ebiomedicine|November 14, 2022
HER2DX genomic test in HER2-positive/hormone receptor-positive breast cancer treated with neoadjuvant trastuzumab and pertuzumab: A correlative analysis from the PerELISA trialValentina Guarneri, Fara Bras-Maristany, Maria Vittoria Dieci, et al.
JAMA Oncology|February 13, 2025
Tumor-Infiltrating Lymphocytes and Survival Outcomes in Early ERBB2-Positive Breast Cancer: 10-Year Analysis of the ShortHER Randomized Clinical TrialMaria Vittoria Dieci, Giancarlo Bisagni, Stefania Bartolini, et al.
Cancers|April 30, 2021
Clinical, Pathological and Prognostic Features of Rare BRAF Mutations in Metastatic Colorectal Cancer (mCRC): A Bi-Institutional Retrospective Analysis (REBUS Study)Maria Alessandra Calegari, Lisa Salvatore, Brunella Di Stefano, et al.
Current Oncology (Toronto, Ont.)|August 27, 2025
Bone Health and Endocrine Therapy with Ovarian Function Suppression in Premenopausal Early Breast Cancer: A Real-Life Monocenter Experience with DenosumabAngelachiara Rotondi, Valentina Frescura, Giorgia Arcuri, et al.
Life (Basel, Switzerland)|November 11, 2022
Clinical Stage III NSCLC Patients Treated with Neoadjuvant Therapy and Surgery: The Prognostic Role of Nodal CharacteristicsMarco Chiappetta, Diomira Tabacco, Amedeo Giuseppe Iaffaldano, et al.
Pageof 60